| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 78 |
| 1 | RIVAROXABAN | 71 |
| 2 | PREDNISOLONE | 69 |
| 3 | PREDNISOLONE ORAL | 69 |
| 4 | PREDNISOLONE ORAL SOLUTION | 69 |
| 5 | TACROLIMUS | 64 |
| 6 | CISPLATIN | 61 |
| 7 | ACETAMINOPHEN | 56 |
| 8 | TESTOSTERONE | 56 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 55 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYCODONE AND ASPIRIN | 1 | 0.0196 |
| 1 | ANGIOTENSIN II | 5 | 0.0167 |
| 2 | DIFLORASONE DIACETATE | 3 | 0.0156 |
| 3 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 4 | OLODATEROL RESPIMAT INHALATION SPRAY | 4 | 0.0108 |
| 5 | MEFLOQUINE HYDROCHLORIDE | 1 | 0.0064 |
| 6 | ZONGERTINIB | 1 | 0.0060 |
| 7 | FROVATRIPTAN SUCCINATE | 4 | 0.0050 |
| 8 | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0047 |
| 9 | ANDEXANET ALFA | 3 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 199 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 157 |
| 2 | Factor Xa Inhibitor [EPC] | 119 |
| 3 | Platinum-based Drug [EPC] | 101 |
| 4 | Proton Pump Inhibitor [EPC] | 77 |
| 5 | Androgen [EPC] | 56 |
| 6 | Benzodiazepine [EPC] | 53 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 51 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 50 |
| 9 | Loop Diuretic [EPC] | 49 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 5 | 0.0167 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Androgen [EPC] | 56 | 0.0020 |
| 3 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 40 | 0.0016 |
| 4 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Actinomycin [EPC] | 3 | 0.0014 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 13 | 0.0010 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 8 | 0.0009 |
| 8 | Tetracycline-class Antibacterial [EPC] | 7 | 0.0009 |
| 9 | Surfactant [EPC] | 1 | 0.0009 |